Hematologic malignancies show activated Wnt, JAK/STAT, Hedgehog, and TGF-β pathways that maintain stemness (21), with CD27 crosslinking and CD70 reverse signaling further driving proliferation (21). Here, CD27 is linked to hematologic disorder.